Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vanda Pharmaceuticals (VNDA) Non-Current Deferred Tax Liability (2016 - 2017)

Historic Non-Current Deferred Tax Liability for Vanda Pharmaceuticals (VNDA) over the last 4 years, with Q4 2017 value amounting to -$386000.0.

  • Vanda Pharmaceuticals' Non-Current Deferred Tax Liability fell 15795.8% to -$386000.0 in Q4 2017 from the same period last year, while for Dec 2017 it was -$386000.0, marking a year-over-year decrease of 15795.8%. This contributed to the annual value of -$386000.0 for FY2017, which is 15795.8% down from last year.
  • According to the latest figures from Q4 2017, Vanda Pharmaceuticals' Non-Current Deferred Tax Liability is -$386000.0, which was down 15795.8% from $666000.0 recorded in Q4 2016.
  • Over the past 5 years, Vanda Pharmaceuticals' Non-Current Deferred Tax Liability peaked at $1.1 million during Q4 2015, and registered a low of -$386000.0 during Q4 2017.
  • Over the past 4 years, Vanda Pharmaceuticals' median Non-Current Deferred Tax Liability value was $336000.0 (recorded in 2014), while the average stood at $346500.0.
  • In the last 5 years, Vanda Pharmaceuticals' Non-Current Deferred Tax Liability skyrocketed by 1823333.33% in 2015 and then plummeted by 15795.8% in 2017.
  • Quarter analysis of 4 years shows Vanda Pharmaceuticals' Non-Current Deferred Tax Liability stood at $6000.0 in 2014, then surged by 18233.33% to $1.1 million in 2015, then tumbled by 39.45% to $666000.0 in 2016, then crashed by 157.96% to -$386000.0 in 2017.
  • Its last three reported values are -$386000.0 in Q4 2017, $666000.0 for Q4 2016, and $1.1 million during Q4 2015.